Mistras Group, Inc. delivered a strong second quarter in 2025, achieving a record Adjusted EBITDA of $24.1 million, an 8.9% increase year-over-year. Despite a slight revenue decrease of 2.3% (flat excluding voluntary Laboratory consolidations), the company significantly expanded its gross profit margin by 200 basis points to 29.1% due to an improved business mix and operating efficiencies. Net income for the quarter was $3.0 million, with non-GAAP diluted EPS of $0.19.
Revenue for Q2 2025 was $185.4 million, a 2.3% decrease year-over-year, but flat when excluding voluntary Laboratory consolidations.
Gross profit increased by 5.1% to $53.9 million, with the gross profit margin expanding by 200 basis points to 29.1%.
Adjusted EBITDA reached an all-time high for a second quarter at $24.1 million, an 8.9% increase from the prior year, with an Adjusted EBITDA margin of 13.0%.
Net income was $3.0 million ($0.10 EPS), while non-GAAP net income excluding special items was $5.8 million ($0.19 non-GAAP diluted EPS).
Mistras Group is not providing full-year guidance for fiscal 2025 as the CEO and renewed senior management team are still reviewing the company’s entire portfolio of businesses and continuously assessing market volatility. However, the company expects its 2025 Adjusted EBITDA to exceed the 2024 level, which was the second highest annual level achieved all-time.
Visualization of income flow from segment revenue to net income